Introduction: Lung cancer is a cancer of high incidence and mortality. The identification of PD-L1 immunoexpression has enabled new treatments with monoclonal antibodies, and the PCR technique for researching EGFR changes allows indicating treatment with tyrosine kinase inhibitors. Objective: to evaluate the immunohistochemical profile and EGFR changes in a series of lung cancer samples. Methodology: Retrospect...
Lung cancer is one the most frequent cause of cancer death in Brazil and worldwide. The advent of new drugs directed towards specific molecular alterations, such as anti-tyrosine kinase for EGFR mutation (Epidermal Growth Factor Receptor) and for the rearrangement of the ALK (Anaplastic Lymphoma Kinase) gene and immunotherapy for PD-L1 (Cell Death Ligant 1 Receptor)expression brought an important gain in overal...